{"id":44119,"date":"2022-05-19T14:01:43","date_gmt":"2022-05-19T12:01:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/"},"modified":"2022-05-19T14:01:43","modified_gmt":"2022-05-19T12:01:43","slug":"biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/","title":{"rendered":"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director"},"content":{"rendered":"
\n

\nThe appointment will support Biognosys\u2019 transformation to a leading provider of protein insights for the development of new breakthrough treatments\n<\/p>\n

<\/a>
<\/a><\/p>\n

ZURICH–(BUSINESS WIRE)–#ClinicalResearch<\/a>–Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, announced today the appointment of Beat L\u00fcthi, Ph.D., as Board Director.\n<\/p>\n

\nDr. L\u00fcthi is Chief Executive Officer of CTC Analytics AG, a privately owned Swiss company leading in automation and advanced laboratory sample handling solutions for the pharmaceutical, life science, chemical, environmental, and food & flavor industries. Additionally, he holds several Board of Directors mandates in public firms, including Chairman of Inficon Group, Vice Chairman of Straumann Group, and Board Member of Skan AG.\n<\/p>\n

\nDr. L\u00fcthi holds an M.Sc. in Electrical Engineering and a Ph.D. in Business Administration from ETH Zurich and completed an International Executive Program at the INSEAD Business School.\n<\/p>\n

\nAs Board Director at Biognosys, Dr. L\u00fcthi will be instrumental in the company\u2019s transformation to a leading provider and partner for protein insights to drive the development of new breakthrough treatments.\n<\/p>\n

\n\u201cI am excited to join Biognosys at a time when proteomics is widely adopted to accelerate life science research and development,\u201d said Dr. L\u00fcthi, incoming Board Director at Biognosys. <\/b>\u201cThe company is at an inflection point of strengthening its global leadership position in the proteomics field and I am looking forward to being part of this journey.\u201d\n<\/p>\n

\n\u201cI am delighted to welcome Dr. L\u00fcthi as Board Director to support our next growth stage with his extensive experience as life sciences executive and board director,\u201d commented Dr. Oliver Rinner, CEO of Biognosys. <\/b>I would also like to thank our prior Board Director, Winfried Mayer, for his many years of invaluable service to our board.\u201d\n<\/p>\n

\nAbout Biognosys<\/b>\n<\/p>\n

\nAt Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that can dramatically improve human health. We enable life science researchers and drug hunters to look at the proteome from every angle with our versatile portfolio of proprietary next-generation proteomics services, software, and kits, including the TrueDiscovery\u2122, TrueTarget\u2122, and TrueSignature\u2122 platforms and flagship software Spectronaut\u2122. These solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Biognosys\u2019 unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins across thousands of samples with industry-leading precision, depth, and throughput. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research. For more information, visit biognosys.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nYves Serroen<\/b>
Head of Marketing and Communications
\n
Phone +41 (0) 79 571 09 21
\n
yves.serroen@biognosys.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The appointment will support Biognosys\u2019 transformation to a leading provider of protein insights for the development of new breakthrough treatments ZURICH–(BUSINESS WIRE)–#ClinicalResearch–Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, announced today the appointment of Beat L\u00fcthi, Ph.D., as Board Director. Dr. L\u00fcthi is Chief Executive Officer of CTC Analytics … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44119","6":"format-standard","7":"category-industry"},"yoast_head":"\nBiognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The appointment will support Biognosys\u2019 transformation to a leading provider of protein insights for the development of new breakthrough treatments ZURICH–(BUSINESS WIRE)–#ClinicalResearch–Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, announced today the appointment of Beat L\u00fcthi, Ph.D., as Board Director. Dr. L\u00fcthi is Chief Executive Officer of CTC Analytics ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-19T12:01:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220519005079\/en\/1459973\/21\/PR_BeatLuethi_Simple_QuoteCard.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director\",\"datePublished\":\"2022-05-19T12:01:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/\"},\"wordCount\":446,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005079\\\/en\\\/1459973\\\/21\\\/PR_BeatLuethi_Simple_QuoteCard.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/\",\"name\":\"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005079\\\/en\\\/1459973\\\/21\\\/PR_BeatLuethi_Simple_QuoteCard.jpg\",\"datePublished\":\"2022-05-19T12:01:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005079\\\/en\\\/1459973\\\/21\\\/PR_BeatLuethi_Simple_QuoteCard.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005079\\\/en\\\/1459973\\\/21\\\/PR_BeatLuethi_Simple_QuoteCard.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/","og_locale":"en_US","og_type":"article","og_title":"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director - Pharma Trend","og_description":"The appointment will support Biognosys\u2019 transformation to a leading provider of protein insights for the development of new breakthrough treatments ZURICH–(BUSINESS WIRE)–#ClinicalResearch–Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, announced today the appointment of Beat L\u00fcthi, Ph.D., as Board Director. Dr. L\u00fcthi is Chief Executive Officer of CTC Analytics ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-19T12:01:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220519005079\/en\/1459973\/21\/PR_BeatLuethi_Simple_QuoteCard.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director","datePublished":"2022-05-19T12:01:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/"},"wordCount":446,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220519005079\/en\/1459973\/21\/PR_BeatLuethi_Simple_QuoteCard.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/","url":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/","name":"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220519005079\/en\/1459973\/21\/PR_BeatLuethi_Simple_QuoteCard.jpg","datePublished":"2022-05-19T12:01:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220519005079\/en\/1459973\/21\/PR_BeatLuethi_Simple_QuoteCard.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220519005079\/en\/1459973\/21\/PR_BeatLuethi_Simple_QuoteCard.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Biognosys Announces Appointment of Beat L\u00fcthi, Ph.D., as independent Board Director"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44119"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44119\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}